SLC6A2 - solute carrier family 6 member 2 Gene
Also Known as NET; NAT1; NET1; SLC6A5
Species: Homo sapiens
About SLC6A2
This gene has 10 transcripts (splice variants), 202 orthologues, 19 paralogues and is associated with 2 phenotypes. Biased expression in adrenal (RPKM 4.7), placenta (RPKM 2.3) and 3 other tissues.
Summary
This gene encodes a member of the sodium:neurotransmitter symporter family. This member is a multi-pass membrane protein, which is responsible for reuptake of norepinephrine into presynaptic nerve terminals and is a regulator of norepinephrine homeostasis. Mutations in this gene cause orthostatic intolerance, a syndrome characterized by lightheadedness, fatigue, altered mentation and syncope. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene.[provided by RefSeq, Feb 2010]
SLC6A2 Products (4)
| mRNA | Protein | Name |
|---|---|---|
| NM_001043.3 | NP_001034.1 | sodium-dependent noradrenaline transporter isoform 2 |
| NM_001172501.3 | NP_001165972.1 | sodium-dependent noradrenaline transporter isoform 2 |
| NM_001172502.1 | NP_001165973.1 | sodium-dependent noradrenaline transporter isoform 3 |
| NM_001172504.1 | NP_001165975.1 | sodium-dependent noradrenaline transporter isoform 1 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables actin binding |
IPI
IPI: Inferred from physical interaction
|
18331289 | GOA |
| enables dopamine:sodium symporter activity |
IDA
IDA: Inferred from direct assay
|
8125921 | GOA |
| enables monoamine transmembrane transporter activity |
IDA
IDA: Inferred from direct assay
|
16024787 | GOA |
| enables norepinephrine:sodium symporter activity |
IDA
IDA: Inferred from direct assay
|
2008212 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
11343649 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| acts upstream of or within monoamine transport |
IDA
IDA: Inferred from direct assay
|
16024787 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in plasma membrane |
IDA
IDA: Inferred from direct assay
|
11343649 | GOA |
SLC6A2 Protein Structure
SNF: Sodium:neurotransmitter symporter family (56 - 579)
- 0
- 100
- 200
- 300
- 400
- 500
- 617 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
sodium-dependent noradrenaline transporter |
|
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Orthostatic Intolerance |
|
|
| Syncope |
|
|
| Oppositional Defiant Disorder |
|
|
| Generalized Anxiety Disorder |
|
|
| Attention Deficit-Hyperactivity Disorder |
|
|
| Major Depressive Disorder |
|
|
| Cocaine Abuse |
|
|
| Panic Disorder |
|
|
| Postural Orthostatic Tachycardia Syndrome |
|
|
| Pheochromocytoma |
|
|
| Ocular Hyperemia |
|
|
| Brittle Cornea Syndrome 2 |
|
|
| Dopamine Beta-Hydroxylase Deficiency |
|
|
| Anorexia Nervosa |
|
|
| Amphetamine Abuse |
|
|
| Anxiety |
|
|
| Mood Disorder |
|
|
| Constipation |
|
|
| Agoraphobia |
|
|
| Bipolar Disorder |
|
|
| Gilles De La Tourette Syndrome |
|
|
| Parkinsonism |
|
|
| Neuroendocrine Tumor |
|
|
| Pyromania |
|
|
| Hyperekplexia |
|
|
| Malignant Pheochromocytoma |
|
|
| Adrenal Medulla Cancer |
|
|
| Specific Developmental Disorder |
|
|
| Central Nervous System Disease |
|
|
| Dysthymic Disorder |
|
|
| Cocaine Dependence |
|
|
| Mental Depression |
|
|
| Schizophrenia |
|
|
| Hypertension, Essential |
|
|
| Tic Disorder |
|
|
| Neuroblastoma |
|
|
| Parkinson Disease, Late-Onset |
|
|
| Body Mass Index Quantitative Trait Locus 11 |
|
|
| Alzheimer Disease, Familial, 1 |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Rattus norvegicus | SLC6A2 | RGD | RGD:621822 |
| Canis familiaris | SLC6A2 | VGNC | VGNC:46462 |
| Bos taurus | SLC6A2 | VGNC | VGNC:34920 |
| Felis catus | SLC6A2 | VGNC | VGNC:65413 |
| Macaca mulatta | SLC6A2 | VGNC | VGNC:77618 |
| Mus musculus | SLC6A2 | MGD | MGI:1270850 |
| Others | SLC6A2 | NCBI |